Function International PCL
SET:FTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Function International PCL
SET:FTI
|
TH |
|
R
|
Reelcause Inc
OTC:RCIT
|
US |
|
Suzano SA
BOVESPA:SUZB3
|
BR |
|
Q
|
Quest Capital Markets Ltd
BSE:500069
|
IN |
|
S
|
Shandong Tengda Fasten Tech Co Ltd
SZSE:001379
|
CN |
|
Treatt PLC
LSE:TET
|
UK |
|
Fumakilla Ltd
TSE:4998
|
JP |
|
L
|
LZ Technology Holdings Ltd
NASDAQ:LZMH
|
CN |
|
ContextVision AB
OSE:CONTX
|
SE |
|
Nexi SpA
MIL:NEXI
|
IT |
|
Kaneka Corp
TSE:4118
|
JP |
|
XiAn Sinofuse Electric Co Ltd
SZSE:301031
|
CN |
|
UeSTRA Hannoversche Verkehrsbetriebe AG
F:HVB
|
DE |
|
Prosafe SE
OSE:PRS
|
NO |
|
Ikka Holdings Co Ltd
TSE:7127
|
JP |
|
N
|
Nanoform Finland Oyj
OMXH:NANOFH
|
FI |
|
F
|
FinecoBank Banca Fineco SpA
OTC:FCBBF
|
IT |
|
RM PLC
LSE:RM
|
UK |
|
G
|
Global Connections PCL
SET:GC
|
TH |
|
WDB Holdings Co Ltd
TSE:2475
|
JP |
|
C
|
Case Group AB
STO:CASE
|
SE |
|
Lecip Holdings Corp
TSE:7213
|
JP |
|
B
|
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
|
CN |
|
Zhejiang Dahua Technology Co Ltd
SZSE:002236
|
CN |
Balance Sheet
Balance Sheet Decomposition
Function International PCL
Function International PCL
Balance Sheet
Function International PCL
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
4
|
6
|
29
|
11
|
228
|
78
|
82
|
|
| Cash Equivalents |
4
|
6
|
29
|
11
|
228
|
78
|
82
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
48
|
51
|
52
|
60
|
68
|
73
|
89
|
|
| Accounts Receivables |
47
|
50
|
52
|
60
|
68
|
73
|
88
|
|
| Other Receivables |
1
|
0
|
1
|
0
|
1
|
1
|
1
|
|
| Inventory |
364
|
382
|
291
|
280
|
326
|
472
|
392
|
|
| Other Current Assets |
1
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Total Current Assets |
416
|
439
|
373
|
352
|
623
|
625
|
563
|
|
| PP&E Net |
161
|
177
|
167
|
191
|
231
|
422
|
404
|
|
| Intangible Assets |
8
|
7
|
6
|
7
|
6
|
5
|
4
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
5
|
4
|
|
| Other Long-Term Assets |
5
|
8
|
8
|
18
|
12
|
9
|
10
|
|
| Total Assets |
589
N/A
|
631
+7%
|
554
-12%
|
568
+2%
|
871
+53%
|
1 066
+22%
|
986
-7%
|
|
| Liabilities | ||||||||
| Accounts Payable |
45
|
55
|
56
|
43
|
43
|
58
|
27
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
178
|
220
|
130
|
118
|
82
|
248
|
183
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
10
|
1
|
1
|
1
|
|
| Other Current Liabilities |
11
|
3
|
9
|
5
|
2
|
4
|
5
|
|
| Total Current Liabilities |
235
|
277
|
195
|
176
|
128
|
311
|
217
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
3
|
5
|
|
| Other Liabilities |
11
|
23
|
32
|
34
|
33
|
39
|
45
|
|
| Total Liabilities |
246
N/A
|
300
+22%
|
227
-24%
|
212
-7%
|
161
-24%
|
352
+118%
|
269
-24%
|
|
| Equity | ||||||||
| Common Stock |
200
|
225
|
225
|
320
|
450
|
450
|
450
|
|
| Retained Earnings |
143
|
105
|
102
|
36
|
77
|
81
|
85
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
182
|
182
|
182
|
|
| Total Equity |
343
N/A
|
330
-4%
|
327
-1%
|
356
+9%
|
710
+99%
|
713
+0%
|
717
+1%
|
|
| Total Liabilities & Equity |
589
N/A
|
631
+7%
|
554
-12%
|
568
+2%
|
871
+53%
|
1 066
+22%
|
986
-7%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
450
|
450
|
450
|
450
|
450
|
450
|
450
|
|